Atrys Health, S.A. (BME:ATRY)
2.830
-0.040 (-1.39%)
Apr 7, 2026, 5:35 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €214.72 million as of April 7, 2026. Its market cap has decreased by -7.89% in one year.
Market Cap
214.72M
Enterprise Value
354.33M
Revenue
145.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.83
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 214.72M, an increase of 1,103.27%. That is a compound annual growth rate of 29.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 214.72M | -3.41% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 4.23B |
| Almirall | 2.65B |
| Pharma Mar | 1.58B |
| Faes Farma | 1.46B |
| Clínica Baviera | 767.29M |
| Prim, S.A. | 216.95M |
| Oryzon Genomics | 216.26M |